Drug Shortage Report for OXERVATE
| Report ID | 201866 |
| Drug Identification Number | 02485613 |
| Brand name | OXERVATE |
| Common or Proper name | CENEGERMIN |
| Company Name | DOMPÉ FARMACEUTICI S.P.A. |
| Market Status | DORMANT |
| Active Ingredient(s) | |
| Strength(s) | 0.002% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 7 X 1 ML OXERVATE MULTIDOSE GLASS VIALS |
| ATC code | S01XA |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-08-30 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-08-31 |
| Company comments | SUPPLY OF CANADIAN LABELLED OXERVATE IS BEING DEPLETED/NEAR EXPIRY AND CANNOT BE REPLENISHED DUE TO LIMITED DEMAND AND SUPPLY CHALLENGES. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | VIA SANTA LUCIA, 6 MILANO, MILAN ITALY 20122 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-08-31 | English | Compare |
| v3 | 2023-08-15 | French | Compare |
| v2 | 2023-08-15 | English | Compare |
| v1 | 2023-08-15 | English | Compare |
Showing 1 to 4 of 4